|
|
Volumn 1, Issue 3, 2008, Pages 217-225
|
|
Should dual antiplatelet therapy after drug-eluting stents be continued for more than 1 year?: Dual antiplatelet therapy after drug-eluting stents should be continued for more than one year and preferably indefinitely.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACETYLSALICYLIC ACID;
ANTITHROMBOCYTIC AGENT;
CLOPIDOGREL;
DRUG DERIVATIVE;
TICLOPIDINE;
ACUTE CORONARY SYNDROME;
ARTICLE;
BLEEDING;
CHEMICALLY INDUCED DISORDER;
CORONARY ARTERY THROMBOSIS;
DRUG COMBINATION;
DRUG ELUTING STENT;
HEART INFARCTION;
HUMAN;
PATIENT SELECTION;
RESTENOSIS;
TIME;
TRANSLUMINAL CORONARY ANGIOPLASTY;
ACUTE CORONARY SYNDROME;
ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY;
ASPIRIN;
CORONARY RESTENOSIS;
CORONARY THROMBOSIS;
DRUG THERAPY, COMBINATION;
DRUG-ELUTING STENTS;
HEMORRHAGE;
HUMANS;
MYOCARDIAL INFARCTION;
PATIENT SELECTION;
PLATELET AGGREGATION INHIBITORS;
TICLOPIDINE;
TIME FACTORS;
|
|
EID: 67649849288
PISSN: None
EISSN: 19417632
Source Type: Journal
DOI: 10.1161/CIRCINTERVENTIONS.108.811380 Document Type: Article |
|
Times cited : (14)
|
|
References (0)
|
